Panacea Biotec logo

Panacea Biotec

See Panacea Biotec's full profile

BOOK A DEMO
Headquarters

India

Founded Year

2019

Total Funding

$168.3M

Employees

1000+

Status

Terminated


About Panacea Biotec

Panacea Biotec is India’s highly progressive research based health management company involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines and natural products.

Headquarters

New Delhi, India


General Information on Panacea Biotec

Brand name Panacea Biotec
Company name Panacea Biotec Ltd.
Website http://panacea-biotec.com/
Founded year 2019
Employees 1000+
Founding team

Soshil Kumar Jain

Contact

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Panacea Biotec

Menafn.com 19.09.2022
Orthopedic Regenerative Medicine Market To Reach US$ 15,891.9 Million With A CAGR Of 10.8% By 2028

Orthopedic Regenerative Medicine Market Regenerative medicines can be consider as manufacturing of pharmaceuticals for the regrowth of cells, replacing damaged cells, organs, or tissues. SEATTLE, WASHINGTON, UNITED STATES, September 19, 2022 /EINPresswire.com / -- Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their ...

EIN News 19.09.2022
Africa Injectable Drugs Market to Surpass US$ 410.9 Mn with a CAGR of 4.7% by 2030

Injectable drugs are injected by various routes of administration, such as intravenous, intramuscular, sub-cutaneous, etc. SEATTLE, WASHINGTON, UNITED STATES, September 19, 2022 / EINPresswire.com / -- Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the ...

Panacea Biotec news
PharmaCompass 15.09.2022
BMS’ Sotyktu wins first nod in plaque psoriasis; Revance’s anti-wrinkle drug to take on AbbVie’s Botox

In pharma news this week, Bristol Myers Squibb’s oral drug Sotyktu (deucravacitinib) has been approved by the US Food and Drug Administration (FDA) as a treatment for patients with moderate-to-severe plaque psoriasis. Sotyktu, a drug that BMS had acquired through its US$ 74 billion buyout of Celgene, is the only TYK2 inhibitor in the world to be approved for this condition. In other approval news, the FDA has given a thumbs up to Revance ...

Panacea Biotec news
FOX 40 WICZ TV 15.09.2022
Everolimus Drug market is projected to grow with magnificent CAGR| Exclusive Report Spread Across 93 Pages

[93 Report Pages] " Everolimus Drug Market " Insights 2022 By Types (2.5mg Tables, 5mg Tables, 10mg Tables, Dispersible Tablet, ), Applications (Kidney Cancer, Immune Rejection of Organ Transplantation, Subependymal Giant Cell Astrocytoma (SEGA), Pancreatic Neuroendocrine Tumors, Breast Cancer, Tuberous Sclerosis Complex-associated Partial-onset Seizures, ), By Segmentation, Regions and Forecast to 2028. The Global Everolimus Drug market Report ...

Panacea Biotec news
Indiainfoline News Service (India) 29.08.2022
Panacea Biotec to conduct AGM

On 28 September 2022 August 29, 2022 10:55 IST| capital market Panacea Biotec announced that the 38th Annual General Meeting of the company will be held on 28 September 2022.

Business Line (India) 23.08.2022
Variant-proof Covid-19 vaccines in the offing

Vaccine-makers are coming out with variant-specific Covid-19 vaccines, as off-shoots of the Omicron variant of the SARS-CoV-2 virus continue to drive an increase in cases around the world. Russia’s Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) said on Tuesday that the Sputnik V vaccine had been specifically adapted against Delta and Omicron variants of Covid. The announcement ...

Panacea Biotec news
OpenPR 18.08.2022
Meningitis Vaccine Market Investment Activity From Established Companies Are to Create Attractive Opportunity for New Comers

What is Meningitis Vaccine?Meningitis is an infection (swelling) of the defensive layers that are called meninges covering the brain and spinal cord. Bacterial or viral contagion of the fluid surrounding the brain and spinal cord ordinarily causes the swelling. However, wounds, disease, certain medications, and different kinds of infections can also cause meningitis. Additionally, bacterial meningitis can cause permanent disabilities, such as ...

Panacea Biotec news
Open PR 18.08.2022
Taxane Market Is Growing With A CAGR Of 7.6% In The Forecast Period Of 2029

08-18-2022 10:38 AM CET | Health & Medicine Press release from: Data Bridge Market Research Taxane The persuasive Taxane market research report is a meticulous investigation of current scenario of the global market which covers several market dynamics. With the use of up to date and proven tools and techniques, complex market insights are organized in simpler version in the world class report for the better understanding of end user. This ...

Panacea Biotec news
EIN News 17.08.2022
Vaccine Market is likely to grow at a CAGR of 9.22%, Opportunities, Revenue, Industry Trends and Growth Forecast by 2029

Data Bridge Market Research analyses that the vaccine market will grow at a CAGR of 9.22% during the forecast period of 2022 to 2029. NEW YORK, UNITED STATES, August 17, 2022 / EINPresswire.com / -- The comprehensive industry research on “ Vaccine Market ” published by Data Bridge Market research includes growth analysis, regional marketing, challenges, opportunities, and drivers analyzed in the report. The transparent, trustworthy and ...

Panacea Biotec news
Menafn.com 16.08.2022
Vaccines Global Market Estimated To Grow At 29% Rate

Vaccines Global Market Report 2022: Market Size, Trends And Forecast To 2026 The Business Research Company's Vaccines Global Market Report 2022: Market Size, Trends And Forecast To 2026 LONDON, GREATER LONDON, UK, August 15, 2022 /EINPresswire.com / -- As per The Business Research Company's 'Vaccines Global Market Report 2022”, the vaccines market is expected to grow from $92.70 billion in 2021 to $105.20 billion in 2022 at a compound annual ...

Panacea Biotec news